These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 3080046)

  • 1. Ultrasound scanning in the detection of hepatic fibrosis and steatosis.
    Saverymuttu SH; Joseph AE; Maxwell JD
    Br Med J (Clin Res Ed); 1986 Jan; 292(6512):13-5. PubMed ID: 3080046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is ultrasonography useful in the assessment of diffuse parenchymal liver disease?
    Sanford NL; Walsh P; Matis C; Baddeley H; Powell LW
    Gastroenterology; 1985 Jul; 89(1):186-91. PubMed ID: 3891495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of ultrasonography in the diagnosis of diffuse liver disease].
    Berrut C; Curati W; de Gautard R; Widmann JJ; Godin N; Loizeau E
    Schweiz Med Wochenschr; 1986 Feb; 116(7):215-8. PubMed ID: 3513304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease.
    Joseph AE; Saverymuttu SH; al-Sam S; Cook MG; Maxwell JD
    Clin Radiol; 1991 Jan; 43(1):26-31. PubMed ID: 1999069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Distribution of Liver Steatosis, Fibrosis, Steatohepatitis and Inflammation Activity in Alcoholics According to FibroMax Test.
    Gudowska M; Wojtowicz E; Cylwik B; Gruszewska E; Chrostek L
    Adv Clin Exp Med; 2015; 24(5):823-7. PubMed ID: 26768633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases.
    Mathiesen UL; Franzén LE; Aselius H; Resjö M; Jacobsson L; Foberg U; Frydén A; Bodemar G
    Dig Liver Dis; 2002 Jul; 34(7):516-22. PubMed ID: 12236486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver steatosis quantification using magnetic resonance imaging: a prospective comparative study with liver biopsy.
    Mennesson N; Dumortier J; Hervieu V; Milot L; Guillaud O; Scoazec JY; Pilleul F
    J Comput Assist Tomogr; 2009; 33(5):672-7. PubMed ID: 19820490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Echomorphological comparisons in chronic diseases of the liver].
    Iakhontova OI; Dudanova OP; Gur'ianova SD; Popova TV
    Ter Arkh; 1989; 61(2):52-5. PubMed ID: 2658194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective evaluation of the diagnostic accuracy of liver ultrasonography.
    Debongnie JC; Pauls C; Fievez M; Wibin E
    Gut; 1981 Feb; 22(2):130-5. PubMed ID: 7215943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of computed tomography, ultrasound and scintigraphy in the diagnosis of alcoholic liver disease.
    Meek DR; Mills PR; Gray HW; Duncan JG; Russell RI; McKillop JH
    Br J Radiol; 1984 Jan; 57(673):23-7. PubMed ID: 6704644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient Elastography and Controlled Attenuation Parameter for Diagnosing Liver Fibrosis and Steatosis in Ontario: An Economic Analysis.
    Thavorn K; Coyle D
    Ont Health Technol Assess Ser; 2015; 15(19):1-58. PubMed ID: 26664666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of ultrasound tomography in the diagnosis of liver diseases].
    Busse HJ; Drescher T; Letterer H; Nilius R
    Dtsch Z Verdau Stoffwechselkr; 1986; 46(3):171-6. PubMed ID: 3530708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of bright liver echo pattern in patients with chronic hepatitis C: correlation with steatosis and fibrosis.
    Loy M; Serra G; Chessa L
    J Ultrasound; 2016; 19(2):91-8. PubMed ID: 27298639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of ultrasound in normal liver and diffuse liver disease in vivo.
    Maklad NF; Ophir J; Balsara V
    Ultrason Imaging; 1984 Apr; 6(2):117-25. PubMed ID: 6539974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography.
    Myers RP; Pollett A; Kirsch R; Pomier-Layrargues G; Beaton M; Levstik M; Duarte-Rojo A; Wong D; Crotty P; Elkashab M
    Liver Int; 2012 Jul; 32(6):902-10. PubMed ID: 22435761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases.
    Ballestri S; Nascimbeni F; Baldelli E; Marrazzo A; Romagnoli D; Targher G; Lonardo A
    Metabolism; 2017 Jul; 72():57-65. PubMed ID: 28641784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: assessment of non-invasive indices predicting hepatic steatosis and fibrosis.
    Polyzos SA; Goulis DG; Kountouras J; Mintziori G; Chatzis P; Papadakis E; Katsikis I; Panidis D
    Hormones (Athens); 2014; 13(4):519-31. PubMed ID: 25402369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasound based evaluation of hepatic steatosis and fibrosis in hepatitis C non-responders.
    Sohail S; Aziz S; Mirza T
    J Coll Physicians Surg Pak; 2013 Aug; 23(8):548-52. PubMed ID: 23930869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of ultrasonography in diagnosis of hepatocellular disease.
    Gosink BB; Lemon SK; Scheible W; Leopold GR
    AJR Am J Roentgenol; 1979 Jul; 133(1):19-23. PubMed ID: 110064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.